AT296960B - Verfahren zur Herstellung von neuen o-Carboxyphenylamidinen - Google Patents

Verfahren zur Herstellung von neuen o-Carboxyphenylamidinen

Info

Publication number
AT296960B
AT296960B AT333970A AT333970A AT296960B AT 296960 B AT296960 B AT 296960B AT 333970 A AT333970 A AT 333970A AT 333970 A AT333970 A AT 333970A AT 296960 B AT296960 B AT 296960B
Authority
AT
Austria
Prior art keywords
carboxyphenylamidines
preparation
new
Prior art date
Application number
AT333970A
Other languages
English (en)
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Application granted granted Critical
Publication of AT296960B publication Critical patent/AT296960B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/20—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 4
    • C07D265/22—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/16—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT333970A 1967-07-11 1968-07-03 Verfahren zur Herstellung von neuen o-Carboxyphenylamidinen AT296960B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HUCI000718 1967-07-11

Publications (1)

Publication Number Publication Date
AT296960B true AT296960B (de) 1972-03-10

Family

ID=10994339

Family Applications (2)

Application Number Title Priority Date Filing Date
AT635468A AT291221B (de) 1967-07-11 1968-07-03 Verfahren zur Herstellung von neuen o-Carboxyphenylamidinen
AT333970A AT296960B (de) 1967-07-11 1968-07-03 Verfahren zur Herstellung von neuen o-Carboxyphenylamidinen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT635468A AT291221B (de) 1967-07-11 1968-07-03 Verfahren zur Herstellung von neuen o-Carboxyphenylamidinen

Country Status (8)

Country Link
US (1) US3663610A (de)
JP (1) JPS4824385B1 (de)
AT (2) AT291221B (de)
CA (1) CA953298A (de)
FR (1) FR7906M (de)
GB (1) GB1238693A (de)
IL (1) IL30281A (de)
NL (1) NL6809615A (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4021471A (en) * 1974-04-18 1977-05-03 Givaudan Corporation Formamidines useful as ultraviolet light absorbers
EP0225726B1 (de) * 1985-11-08 1991-04-17 Glaxo Group Limited Indolderivate
IT1231238B (it) * 1987-09-21 1991-11-26 Angeli Inst Spa Derivati ammidinici
GB8903592D0 (en) * 1989-02-16 1989-04-05 Boots Co Plc Therapeutic agents

Also Published As

Publication number Publication date
FR7906M (de) 1970-05-11
US3663610A (en) 1972-05-16
NL6809615A (de) 1969-01-14
CA953298A (en) 1974-08-20
DE1768787B2 (de) 1975-09-11
IL30281A0 (en) 1968-09-26
DE1768787A1 (de) 1972-04-20
IL30281A (en) 1971-12-29
JPS4824385B1 (de) 1973-07-20
GB1238693A (de) 1971-07-07
AT291221B (de) 1971-07-12

Similar Documents

Publication Publication Date Title
AT306016B (de) Verfahren zur Herstellung von neuen Pyridinverbindungen
AT299171B (de) Verfahren zur Herstellung von neuen Bis-stilben-Verbindungen
CH532015A (de) Verfahren zur Herstellung von neuen 1-Phenoxy-2-hydroxy-3-alkylaminopropanen
AT277221B (de) Verfahren zur Herstellung von neuen 5-Nitro-2-furyl-2-isoxazolin-derivaten
CH536313A (de) Verfahren zur Herstellung von neuen 2-Cycloalkyl-heteroaryl-Verbindungen
AT295530B (de) Verfahren zur Herstellung von neuen substituierten Benzodioxolen
AT277985B (de) Verfahren zur Herstellung von neuen Nitro-furan-, -thiophen- oder -pyrrol-derivaten
AT275517B (de) Verfahren zur Herstellung von neuen p-Alkoxy-piperidin-amiden
AT293440B (de) Verfahren zur Herstellung von neuen D-Glucofuranosiden
CH518936A (de) Verfahren zur Herstellung von neuen basisch substituierten bis-Piperidylalkanen
AT292684B (de) Verfahren zur Herstellung von neuen Naphthylisopropylaminen
AT294122B (de) Verfahren zur Herstellung von neuen 6-Desoxy-D-xylohexafuranosiden
AT291221B (de) Verfahren zur Herstellung von neuen o-Carboxyphenylamidinen
CH493469A (de) Verfahren zur Herstellung von neuen Diarylacetamiden
CH504451A (de) Verfahren zur Herstellung von neuen 3-Aminoacylaminothiophenen
AT283319B (de) Verfahren zur Herstellung von neuen Azidozimtaldehyden
AT292022B (de) Verfahren zur Herstellung von neuen Disilacyclohexadienen
AT281797B (de) Verfahren zur Herstellung von neuen Dialkylaminoacylaniliden
AT277254B (de) Verfahren zur Herstellung von neuen Benzazepinopyridoindolderivaten
AT279606B (de) Verfahren zur Herstellung von neuen 1-Phenyl-4-alkyl-2-imidazolonen
AT299976B (de) Verfahren zur Herstellung von neuen Disilacyclohexadienen
AT281805B (de) Verfahren zur Herstellung von neuen 5-Nitrofurfurylidenaminooxazolidinonen
AT276408B (de) Verfahren zur Herstellung von neuen 2-Amino-3-carbonamido-chinoxalin-di-N-oxyden
AT294044B (de) Verfahren zur herstellung von neuen 2-alkoxy-5-chlorsulfonylnitrobenzolen
AT285830B (de) Verfahren zur Herstellung von neuen Morphin-3-acetamiden

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee